Effects of SGLT-2 inhibitors and GLP-1 receptor agonists on liver function in patients with non-alcoholic fatty liver disease and type 2 diabetes - Poll - MDSpire

Effects of SGLT-2 inhibitors and GLP-1 receptor agonists on liver function in patients with non-alcoholic fatty liver disease and type 2 diabetes

  • By

  • Wancheng Guo

  • Wenhe Li

  • Xianlin Li

  • Wen Shi

  • Yan Yan

  • Ting Yan

  • Jie Zhou

  • Yujie Huang

  • June 3, 2026

  • 0 min

Share

Original Source(s)

Effects of SGLT-2 inhibitors and GLP-1 receptor agonists on liver function in patients with non-alcoholic fatty liver disease and type 2 diabetes

  • by Wancheng Guo, Wenhe Li, Xianlin Li, Wen Shi, Yan Yan, Ting Yan, Jie Zhou, Yujie Huang

  • June 3, 2026

Related Content

Gov. Patrick Morrisey walking Mountaineer Miles to encourage West Virginians to lose weight

SNAP bans on soda, candy and other foods take effect in five states Jan. 1

The Relationships Between MASLD, Extrahepatic Multimorbidity, and All-Cause Mortality in the UK Biobank Cohort